Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SWX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.
Discovering and developing innovative therapeutics for CNS disorders
Media
Media Contacts
Newron contacts:
Luca Benatti - CEO
Emanuela Germi - Assistant
Phone: +39 02 6103 4 626
E-mail: pr@newron.com
Global Partner: Financial Dynamics
Julia Phillips
Financial Dynamics
Holborn Gate, 26 Southampton Buildings
London WC2A 1PB
UK
Phone: +44 (0) 20 7269 7187
Swiss Partner: The Investors Relations Firm AG
Martin Meier-Pfister
The Investor Relations Firm AG
P.O. Box, Raemistrasse 4, CH-8024 Zuerich
Phone: +41 43 244 81 40
Fax: +41 43 244 81 45